Oral Supplementation of the Vitamin D Metabolite 25(OH)D3 Against Influenza Virus Infection in Mice. 2020

Hirotaka Hayashi, and Masatoshi Okamatsu, and Honami Ogasawara, and Naoko Tsugawa, and Norikazu Isoda, and Keita Matsuno, and Yoshihiro Sakoda
Laboratory of Microbiology, Faculty of Veterinary Medicine, Hokkaido University, Kita 18 Nishi 9, Kita-ku, Sapporo 060-0818, Japan.

Vitamin D is a fat-soluble vitamin that is metabolized by the liver into 25-hydroxyvitamin D [25(OH)D] and then by the kidney into 1,25-dihydroxyvitamin D [1,25(OH)2D], which activates the vitamin D receptor expressed in various cells, including immune cells, for an overall immunostimulatory effect. Here, to investigate whether oral supplementation of 25-hydroxyvitamin D3 [25(OH)D3], a major form of vitamin D metabolite 25(OH)D, has a prophylactic effect on influenza A virus infection, mice were fed a diet containing a high dose of 25(OH)D3 and were challenged with the influenza virus. In the lungs of 25(OH)D3-fed mice, the viral titers were significantly lower than in the lungs of standardly fed mice. Additionally, the proinflammatory cytokines IL-5 and IFN-γ were significantly downregulated after viral infection in 25(OH)D3-fed mice, while anti-inflammatory cytokines were not significantly upregulated. These results indicate that 25(OH)D3 suppresses the production of inflammatory cytokines and reduces virus replication and clinical manifestations of influenza virus infection in a mouse model.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D009976 Orthomyxoviridae Infections Virus diseases caused by the ORTHOMYXOVIRIDAE. Orthomyxovirus Infections,Infections, Orthomyxoviridae,Infections, Orthomyxovirus,Swine Influenza,Infection, Orthomyxoviridae,Infection, Orthomyxovirus,Influenza, Swine,Orthomyxoviridae Infection,Orthomyxovirus Infection
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D002112 Calcifediol The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties. 25-Hydroxycholecalciferol,25-Hydroxyvitamin D 3,25-Hydroxycholecalciferol Monohydrate,25-Hydroxyvitamin D3,Calcidiol,Calcifediol Anhydrous,Calcifediol, (3 alpha,5Z,7E)-Isomer,Calcifediol, (3 beta,5E,7E)-Isomer,Calderol,Dedrogyl,Hidroferol,25 Hydroxycholecalciferol,25 Hydroxycholecalciferol Monohydrate,25 Hydroxyvitamin D 3,25 Hydroxyvitamin D3,Anhydrous, Calcifediol,Monohydrate, 25-Hydroxycholecalciferol
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D014815 Vitamins Organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body. Vitamin
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor

Related Publications

Hirotaka Hayashi, and Masatoshi Okamatsu, and Honami Ogasawara, and Naoko Tsugawa, and Norikazu Isoda, and Keita Matsuno, and Yoshihiro Sakoda
September 2019, Photodermatology, photoimmunology & photomedicine,
Hirotaka Hayashi, and Masatoshi Okamatsu, and Honami Ogasawara, and Naoko Tsugawa, and Norikazu Isoda, and Keita Matsuno, and Yoshihiro Sakoda
April 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Hirotaka Hayashi, and Masatoshi Okamatsu, and Honami Ogasawara, and Naoko Tsugawa, and Norikazu Isoda, and Keita Matsuno, and Yoshihiro Sakoda
January 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
Hirotaka Hayashi, and Masatoshi Okamatsu, and Honami Ogasawara, and Naoko Tsugawa, and Norikazu Isoda, and Keita Matsuno, and Yoshihiro Sakoda
September 2014, Nutrition (Burbank, Los Angeles County, Calif.),
Hirotaka Hayashi, and Masatoshi Okamatsu, and Honami Ogasawara, and Naoko Tsugawa, and Norikazu Isoda, and Keita Matsuno, and Yoshihiro Sakoda
July 2020, Nutritional neuroscience,
Hirotaka Hayashi, and Masatoshi Okamatsu, and Honami Ogasawara, and Naoko Tsugawa, and Norikazu Isoda, and Keita Matsuno, and Yoshihiro Sakoda
January 2024, Advances in nutrition (Bethesda, Md.),
Hirotaka Hayashi, and Masatoshi Okamatsu, and Honami Ogasawara, and Naoko Tsugawa, and Norikazu Isoda, and Keita Matsuno, and Yoshihiro Sakoda
April 1985, Diabetes,
Hirotaka Hayashi, and Masatoshi Okamatsu, and Honami Ogasawara, and Naoko Tsugawa, and Norikazu Isoda, and Keita Matsuno, and Yoshihiro Sakoda
March 1972, Pediatrie,
Hirotaka Hayashi, and Masatoshi Okamatsu, and Honami Ogasawara, and Naoko Tsugawa, and Norikazu Isoda, and Keita Matsuno, and Yoshihiro Sakoda
January 2012, Medicina,
Hirotaka Hayashi, and Masatoshi Okamatsu, and Honami Ogasawara, and Naoko Tsugawa, and Norikazu Isoda, and Keita Matsuno, and Yoshihiro Sakoda
June 2011, Pathology,
Copied contents to your clipboard!